KRAS G12D-Mutant Advanced or Metastatic Pancreatic Cancer in the First-line Setting

Clinical trial pipeline · Data from ClinicalTrials.gov

See which KRAS G12D-Mutant Advanced or Metastatic Pancreatic Cancer in the First-line Setting trials may be worth asking about

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

Not Yet RecruitingPhase 3

NCT07232875

HRS 4642 Injection Combined With AG Versus Placebo Combined With AG Therapy in First-Line Advanced or Metastatic Pancrea…

This study investigates the first-line treatment of advanced pancreatic cancer with KRAS G12D mutation. Patients were randomized 1:1 to receive either the exper…

China588 participantsStarted 2025-12Updated 2025-11-18

Treatment: HRS-4642 + AG, HRS-4642 placebo + AG